Lidocaine Analgesia for Urethral Catheterization in Children

• Status: Completed
• Trial end date: 2015-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Primary Aim

1. To measure difference in pain via Faces, Legs, Activity, Cry and Consolability (FLACC) Pain Scale score at the time of transurethral bladder catheterization for urine collection in children who do and do not receive intraurethral 2% lidocaine jelly prior to catheterization.

Secondary Aims

1. To assess gender differences in pain control during transurethral bladder catheterization with and without pain control using intraurethral 2% lidocaine jelly.

2. To assess patient discomfort with administration of intraurethral 2% lidocaine jelly.

To assess parental impression of discomfort between intervention and control groups.

3. To assess pain associated with the administration of intraurethral 2% lidocaine jelly.

4. To measure difference in pain via Modified Behavioral Pain Scale (MBPS) score at the time of TUBC for urine collection in children who do and do not receive intraurethral 2% lidocaine jelly prior to catheterization.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seattle Children's Hospital
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Age 0-3 years

• English or Spanish speaking

• Legal guardian present to provide consent

• Medical indication for TUBC during the patient's ED visit

Exclusion Criteria:

• Severe developmental delay or impaired mentation

• Neural tube defect, paraplegia, or other condition altering urethral sensation

• Known urethral stricture, anatomic abnormality or reconstruction

• History of sexual abuse

• Patient weight less than 2.3 kg

• Allergy or previous adverse reaction to lidocaine

• Previous enrollment in the study

• Prior successful or attempted TUBC in previous 7 days